412 related articles for article (PubMed ID: 28646478)
21. Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study.
Inoue T; Hattori K; Ihara K; Ishii A; Nakamura K; Hirose S
J Hum Genet; 2013 Aug; 58(8):548-52. PubMed ID: 23677059
[TBL] [Abstract][Full Text] [Related]
22. Comparision of fluorimetric and mass spectrometric methods for Fabry disease newborn screening.
Orlov DS; Nazarenko LP; Didenko LI; Seitova GN
Klin Lab Diagn; 2022 Apr; 67(4):204-206. PubMed ID: 35575392
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Fabry's disease within hemodialysis patients in Spain.
Herrera J; Miranda CS
Clin Nephrol; 2014 Feb; 81(2):112-20. PubMed ID: 24365053
[TBL] [Abstract][Full Text] [Related]
24. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
[TBL] [Abstract][Full Text] [Related]
25. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
[TBL] [Abstract][Full Text] [Related]
26. Detection of novel Fabry disease-associated pathogenic variants in Japanese patients by newborn and high-risk screening.
Sawada T; Kido J; Sugawara K; Matsumoto S; Takada F; Tsuboi K; Ohtake A; Endo F; Nakamura K
Mol Genet Genomic Med; 2020 Nov; 8(11):e1502. PubMed ID: 33016649
[TBL] [Abstract][Full Text] [Related]
27. The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease.
Hasholt L; Ballegaard M; Bundgaard H; Christiansen M; Law I; Lund AM; Norremolle A; Krogh Rasmussen A; Ravn K; Tumer Z; Wibrand F; Feldt-Rasmussen U
Scand J Clin Lab Invest; 2017 Dec; 77(8):617-621. PubMed ID: 29037082
[TBL] [Abstract][Full Text] [Related]
28. Newborn genetic screening for Fabry disease: Insights from a retrospective analysis in Nanjing, China.
Sun Y; Guan XW; Wang YY; Hong DY; Zhang ZL; Li YH; Yang PY; Wang X; Jiang T; Chi X
Clin Chim Acta; 2024 Apr; 557():117889. PubMed ID: 38531466
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R
Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550
[TBL] [Abstract][Full Text] [Related]
30. Impact of
Monda E; Diana G; Graziani F; Rubino M; Bakalakos A; Linhart A; Germain DP; Scarpa M; Biagini E; Pieroni M; Elliott PM; Limongelli G
Circ Genom Precis Med; 2023 Dec; 16(6):e004252. PubMed ID: 38047356
[TBL] [Abstract][Full Text] [Related]
31. Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience.
Effraimidis G; Rasmussen ÅK; Dunoe M; Hasholt LF; Wibrand F; Sorensen SS; Lund AM; Kober L; Bundgaard H; Yazdanfard PDW; Oturai P; Larsen VA; Fraga de Abreu VH; Enevoldsen LH; Kristensen T; Svenstrup K; Bille MB; Arif F; Mogensen M; Klokker M; Backer V; Kistorp C; Feldt-Rasmussen U
PLoS One; 2022; 17(11):e0277767. PubMed ID: 36383556
[TBL] [Abstract][Full Text] [Related]
32. Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology.
Caudron E; Prognon P; Germain DP
Eur J Med Genet; 2015 Dec; 58(12):681-4. PubMed ID: 26520229
[TBL] [Abstract][Full Text] [Related]
33. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic
Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ
J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335
[TBL] [Abstract][Full Text] [Related]
34. Functional and Clinical Consequences of Novel α-Galactosidase A Mutations in Fabry Disease.
Lukas J; Scalia S; Eichler S; Pockrandt AM; Dehn N; Cozma C; Giese AK; Rolfs A
Hum Mutat; 2016 Jan; 37(1):43-51. PubMed ID: 26415523
[TBL] [Abstract][Full Text] [Related]
35. Screening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation.
Baptista A; Magalhães P; Leão S; Carvalho S; Mateus P; Moreira I
Arq Bras Cardiol; 2015 Aug; 105(2):139-44. PubMed ID: 26269958
[TBL] [Abstract][Full Text] [Related]
36. Detection of α-Galactosidase A Reaction in Samples Extracted from Dried Blood Spots Using Ion-Sensitive Field Effect Transistors.
Kuznetsov A; Sheshil A; Smolin E; Grudtsov V; Ryazantsev D; Shustinskiy M; Tikhonova T; Kitiashvili I; Vechorko V; Komarova N
Sensors (Basel); 2024 Jun; 24(11):. PubMed ID: 38894470
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
Duro G; Zizzo C; Cammarata G; Burlina A; Burlina A; Polo G; Scalia S; Oliveri R; Sciarrino S; Francofonte D; Alessandro R; Pisani A; Palladino G; Napoletano R; Tenuta M; Masarone D; Limongelli G; Riccio E; Frustaci A; Chimenti C; Ferri C; Pieruzzi F; Pieroni M; Spada M; Castana C; Caserta M; Monte I; Rodolico MS; Feriozzi S; Battaglia Y; Amico L; Losi MA; Autore C; Lombardi M; Zoccali C; Testa A; Postorino M; Mignani R; Zachara E; Giordano A; Colomba P
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477121
[TBL] [Abstract][Full Text] [Related]
38. Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry.
Dajnoki A; Fekete G; Keutzer J; Orsini JJ; De Jesus VR; Chien YH; Hwu WL; Lukacs Z; Mühl A; Zhang XK; Bodamer O
Clin Chim Acta; 2010 Oct; 411(19-20):1428-31. PubMed ID: 20338160
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients.
Duro G; Anania M; Zizzo C; Francofonte D; Giacalone I; D'Errico A; Marsana EM; Colomba P
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791200
[TBL] [Abstract][Full Text] [Related]
40. Newborn screening for Fabry disease in Oregon: Approaching the iceberg of A143T and variants of uncertain significance.
Viall S; Dennis A; Yang A
Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):206-214. PubMed ID: 36156392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
